Quadrant Capital Group
TVTX icon

Quadrant Capital Group’s Travere Therapeutics TVTX Stock Holding History

Quadrant Capital Group’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$272K Sell
5,252
-115
-2% -$7.02K 0.01% 1100
2026
Q2 		$305K Hold
5,367
– – 0.01% 1076
2026
Q1 		$159K Sell
5,367
-883
-14% -$26.4K ﹤0.01% 1337
2025
Q4 		$239K Sell
6,250
-372
-6% -$12.1K 0.01% 1240
2025
Q3 		$158K Buy
+6,622
New +$124K 0.01% 1337
2025
Q2 		– Sell
-6,724
Closed -$120K – 2536
2025
Q1 		$120K Buy
6,724
+102
+2% +$2.07K ﹤0.01% 1483
2024
Q4 		$115K Hold
6,622
– – 0.01% 985
2024
Q3 		$92.6K Hold
6,622
– – 0.01% 1111
2024
Q2 		$54.4K Buy
6,622
+4,554
+220% +$30.7K ﹤0.01% 1362
2024
Q1 		$15.9K Sell
2,068
-391
-16% -$3.3K ﹤0.01% 1937
2023
Q4 		$22.1K Buy
2,459
+2,419
+6,048% +$17.6K ﹤0.01% 1772
2023
Q3 		$358 Buy
+40
New +$564 ﹤0.01% 2618
2023
Q2 		– Sell
-41
Closed -$923 – 2777
2023
Q1 		$923 Buy
+41
New +$872 ﹤0.01% 2547
2021
Q4 		– Sell
-41
Closed -$1K – 2699
2021
Q3 		$1K Buy
+41
New +$753 ﹤0.01% 2399

Other funds holding TVTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Insight Wealth Strategies
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
Sigma Planning Corp
Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Quadrant Capital Group's TVTX Position: Q3 2026 in Review

Quadrant Capital Group reduced its Travere Therapeutics (TVTX) stake by 2.1% in Q3 2026, selling an estimated $7.02K and leaving 5,252 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #1100.

Quadrant Capital Group first reported a position in TVTX in Q3 2021 and has held it in 14 quarters since. The position peaked at $305K in Q2 2026. 35 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Quadrant Capital Group held 5,252 shares of Travere Therapeutics worth $272K as of Q3 2026.
  • Quadrant Capital Group sold 115 Travere Therapeutics shares in Q3 2026, an estimated $7.02K.
  • Travere Therapeutics made up 0.01% of Quadrant Capital Group's portfolio in Q3 2026, its #1100 holding.
  • Quadrant Capital Group first reported a position in Travere Therapeutics in Q3 2021 and has held it in 14 quarters since.
  • Quadrant Capital Group's Travere Therapeutics position peaked at $305K in Q2 2026.
  • 35 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Quadrant Capital Group's 13F filing for Q3 2026, filed 20 Oct 2026.